دورية أكاديمية
Talazoparib monotherapy in metastatic castration-resistant prostate cancer with DNA repair alterations (TALAPRO-1): an open-label, phase 2 trial
العنوان: | Talazoparib monotherapy in metastatic castration-resistant prostate cancer with DNA repair alterations (TALAPRO-1): an open-label, phase 2 trial |
---|---|
المؤلفون: | de Bono, Johann S *, Mehra, Niven, Scagliotti, Giorgio V, Castro, Elena, Dorff, Tanya, Stirling, Adam, Stenzl, Arnulf, Fleming, Mark T, Higano, Celestia S, Saad, Fred, Buttigliero, Consuelo, van Oort, Inge M, Laird, A Douglas, Mata, Marielena, Chen, Hsiang-Chun, Healy, Cynthia G, Czibere, Akos, Fizazi, Karim |
المصدر: | In The Lancet Oncology September 2021 22(9):1250-1264 |
قاعدة البيانات: | ScienceDirect |
كن أول من يترك تعليقا!